Literature DB >> 21128818

Core symptoms that discriminate premenstrual syndrome.

Ellen W Freeman1, Steffanie M Halberstadt, Karl Rickels, Julie M Legler, Hui Lin, Mary D Sammel.   

Abstract

OBJECTIVE: To identify core symptoms that discriminate premenstrual syndrome (PMS) in prospective daily diary ratings and determine the association of these symptoms with functional impairment.
METHODS: The study analyzed prospective daily symptom ratings and functional impairment data provided by 1081 women who requested PMS treatment at an academic medical center. The data were obtained before any treatment procedures. A random-split sample design provided separate developmental and validation datasets. Logistic regression was used to identify a reduced set of symptoms that best discriminated PMS. The results were validated in a separate dataset. Optimal cutoff points in the symptom scores were identified for clinical use.
RESULTS: Statistical modeling identified 6 symptoms that discriminated PMS and not PMS as well as 17 symptoms in daily diary ratings. The identified core symptoms included anxiety/tension, mood swings, aches, appetite/food cravings, cramps, and decreased interest in activities. The area under the curve (AUC) was 0.84 in both models. The sums of the premenstrual symptom scores also discriminated PMS and not PMS and correctly classified 84%-86% of the cases.
CONCLUSIONS: Six symptoms rated in daily diaries discriminate between PMS and not PMS among women seeking treatment and are significantly associated with functional impairment. The findings suggest that the burden of daily diaries to confirm PMS can be reduced to a smaller number of symptoms that distinguish the patients who meet this requirement. Results also support the concept that a clinical diagnosis of PMS can be developed around a core symptom group.

Entities:  

Mesh:

Year:  2010        PMID: 21128818      PMCID: PMC3017419          DOI: 10.1089/jwh.2010.2161

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  23 in total

1.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

Authors:  E W Steyerberg; F E Harrell; G J Borsboom; M J Eijkemans; Y Vergouwe; J D Habbema
Journal:  J Clin Epidemiol       Date:  2001-08       Impact factor: 6.437

Review 2.  The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

Authors:  Uriel Halbreich; Jeff Borenstein; Terry Pearlstein; Linda S Kahn
Journal:  Psychoneuroendocrinology       Date:  2003-08       Impact factor: 4.905

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers' experiences?

Authors:  Shirley Ann Hartlage; Kelly E Arduino
Journal:  Psychol Rep       Date:  2002-02

5.  Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Authors:  Lee S Cohen; Cherri Miner; Eileen W Brown; Ellen Freeman; Uriel Halbreich; Karen Sundell; Susan McCray
Journal:  Obstet Gynecol       Date:  2002-09       Impact factor: 7.661

6.  A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome.

Authors:  Bonnie B Dean; Jeff E Borenstein
Journal:  J Occup Environ Med       Date:  2004-07       Impact factor: 2.162

7.  Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.

Authors:  Julia Potter; Jean Bouyer; James Trussell; Caroline Moreau
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

8.  How does premenstrual dysphoric disorder relate to depression and anxiety disorders?

Authors:  Mikael Landén; Elias Eriksson
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

9.  Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.

Authors:  Ellen W Freeman; Karl Rickels; Steven J Sondheimer; Marcia Polansky; Sha Xiao
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

10.  Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences.

Authors:  J F Mortola; L Girton; L Beck; S S Yen
Journal:  Obstet Gynecol       Date:  1990-08       Impact factor: 7.661

View more
  16 in total

Review 1.  Differences in Symptom Reporting Between Males and Females at Baseline and After a Sports-Related Concussion: A Systematic Review and Meta-Analysis.

Authors:  Dana A Brown; Julie A Elsass; Ashley J Miller; Lauren E Reed; Jennifer C Reneker
Journal:  Sports Med       Date:  2015-07       Impact factor: 11.136

2.  Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue.

Authors:  Doerte U Junghaenel; Stefan Schneider; Arthur A Stone; Christopher Christodoulou; Joan E Broderick
Journal:  J Psychosom Res       Date:  2014-02-07       Impact factor: 3.006

3.  Health related quality of life among adolescents with premenstrual disorders: a cross sectional study.

Authors:  Mahin Delara; Fazlollah Ghofranipour; Parviz Azadfallah; Sedigheh Sadat Tavafian; Anoushirvan Kazemnejad; Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2012-01-01       Impact factor: 3.186

Review 4.  Premenstrual Dysphoric Disorder: Epidemiology and Treatment.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

Review 5.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

6.  Emotion-related impulsivity and rumination predict the perimenstrual severity and trajectory of symptoms in women with a menstrually related mood disorder.

Authors:  Danyelle N Dawson; Tory A Eisenlohr-Moul; Julia L Paulson; Jessica R Peters; David R Rubinow; Susan S Girdler
Journal:  J Clin Psychol       Date:  2017-09-12

Review 7.  Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms.

Authors:  Sarah A Owens; Tory Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2018-10-06       Impact factor: 5.285

8.  Were there evolutionary advantages to premenstrual syndrome?

Authors:  Michael R Gillings
Journal:  Evol Appl       Date:  2014-08-11       Impact factor: 5.183

9.  Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Cav1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling.

Authors:  Chunhong Song; Jieqiong Wang; Dongmei Gao; Yanhong Yu; Fang Li; Sheng Wei; Peng Sun; Meiyan Wang; Mingqi Qiao
Journal:  Biomed Res Int       Date:  2017-12-06       Impact factor: 3.411

10.  Shuyu Capsules Relieve Premenstrual Syndrome Depression by Reducing 5-HT3AR and 5-HT3BR Expression in the Rat Brain.

Authors:  Fang Li; Jizhen Feng; Dongmei Gao; Jieqiong Wang; Chunhong Song; Sheng Wei; Mingqi Qiao
Journal:  Neural Plast       Date:  2016-09-20       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.